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W e have raised polyclonal antibodies against each of three 
subunits of the new basement m embrane component nicein 
(formerly BM-600), the antigen recognized by the monoclo-
nal antibody GB3 (Bio chem Biophys Acta 942:45 - 56, 1988). 
Preparation of such antibodies was achieved from gel elec-
trophoresis purification of niceil~ isol.ated by immu~lO-a~n­
ity chromatography. These antibodies were reactive With 
each transblotted denatured nicein subunit and recognized 
the native protein both in cultured keratinocytes and in all 
normal human basem ent membranes where the GB3 antigen 
is located. A reciprocal immuno-cross-reactivity was detected 
with the antibodies directed against the 100-kD and 150-kD 
(sometimes resolved as a 146-150-kD doublet) subunits of 
nicein, showing that they share some identical epitopes. In 
tissues and keratinocyte cultures from patients with the Her-
litz form of junctional epidermolysis bullosa (H-JEB), GB3 is 
unable to recognize nicein, and the question arises whether 
Epidermolysis bullosa (EB) encompasses several derma-. toses shar!ng the common feature of marked skin fragil-ity and blister formatIOn consequent to mll10r trauma to the skin (1 ,2]. In junctional EB (JEB). blisters occur within the lamina lucida of epidermal basement mem-
brane (BM) (3]. The recent consensus report from the Subcommit-
tee on Diagnosis and Classification of the National Epidermylosis 
Bullosa Registry (U.S.A.) (4] suggests that two main forms of JEB. 
namely. the localized and the generalized types, may be distin-
guished. The severe Herlitz variant (H-JEB) accounts for roughly 
50% of all JEB cases. In H-JEB ultrastructural studies have shown 
abnormalities both in number and structure of hemidesmosomes 
(5 - 8], which are epidermal basal keratinocyte structures similar but 
not identical to half-desmosomes (9 -12]. This feature, although 
not considered an absolute criterion by some authors [8], has been 
used for establishing the prenatal diagnosis of H-JEB (6]. 
The monoclonal antibody GB3 raised against amnion epithelium 
(13] recognizes an epidermal BM antigen weakly detected (15% 
cases) or not detected (85% cases) by immunofluorescence in H-JEB 
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this is due to an absence of synthesis or a structural abnormal_ 
ity of the protein. W e report here that the polyclonal anti-
body directed against the 150-kD subunit of nicein binds its 
antig~n in H-JE~ patients (although usually less intensely 
than m control skm), whereas the other two antibodies either 
do ~ot recognize or recognize only weakly their respective 
antigen subumts . These data suggest that nicein is present but 
structurally altered in basement membranes from H-JEB tis-
sues. Furtl~ermore, in non-Herlitz junctional and dystrophic 
types of epidermolysIs bullosa, all three polyclonal antibodies 
recognize their antigens normally . Consequently, such anti-
bodies should serve as potentially useful molecular tools 
for studyi.ng the expre~sion of ~icein in H-JEB. Key words: 
dermo-epldermal Junctton/henudesmosomes/ epidermal base-
ment membranejkeratinocytes. ] Invest D ermatol 101:738-
743, 1993 
skin samples (14,1 5] . This is observed as early as the 8th week of 
intrauterine life. allowing the use of GB3 for a rapid prenatal diag-
noSIS of the disease [~5 , 16] . We have Identified the GB3 antigen as a 
new BM glycoprotelI1 of approxllna~ely 600 kD molecular weight 
and termed It BM-600 [17,18] or IUCelI1 (1 9]. This protein, made 
from disulfide-bonded polypeptides of 100. 125, and 150 ill 
(sometimes appearing as a 146 - 150-kD doublet) was successfull 
immunoprecipitated from cultures of keratinocytes from health 
donors but not from H-JEB patients or fetuses [20] . Taken together 
these data indicate a possible role for nicein in cell-substrate adhe-
sion and BM cohesion. The weak adhesion of cultured H-JEB kera-
tinocytes to the culture dish observed in lIilro [21.22] reinforces thi 
hypothesis. It is unclear whether the absence of GB3 reactivity in 
H-JEB specimens is due to a loss of the protein or to conformational 
modifications preventing the interaction with GB3. 
In an attempt to provide an answer to this question, we report data 
obtained using polyclonal antibodies prepared from nicein subunits 
purified by acrylamide gel electrophoresis from the protein isolated 
by affinity chromatography. W e also examined the immunoreac-
tivity of these antibodies ill some non-Herlitz JEB (nH-JEB) and 
dystrophic epidermylosis bullosa (DEB) skin samples. 
MATERIALS AND METHODS 
Cell Culture Normal human keratinocytes were cultured according ro 
the method of Rheinwald and Green [23] using an irradiated 3T3 fibroblast 
feeder layer. as described previously [17.18]. H-JEB keratinocytes were cul-
tured as reported in [20]. 
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Table I. Scored Immunofluorescence with GB3, PalOO, 
pa12S, and Pa1S0 Antibodies on Normal and H-JEB Skin" 
Immunoreactivity 
Skin Sample Case Pal00 Pa125 Pa150 GB3 
Normal adult 90-561 +++ +++ +++ +++ 
Normal fetus 87-420 ++ +++ +++ +++ 
87-441 +++ +++ +++ +++ 
1110 +++ +++ +++ +++ 
H-]EB 88-618(f) + + + 
86-418(f) + ++ 
89-706(f) + ++ 
89-732(f) + + 
89-771 (f) + + 
87-471(i) + ++ 
GB-BR{i) + 
GB-JO(i) +++ 
GB-AL(i) +++ 
GB-BI(i) + 
GB-MI(c) + + +++ + 
__ indicates a n absence of fluorescence, whereas +++ indicates a strong fluores-
cence. f, fetus; i, infant; c, child. 
IInmunoaBinity Isolation of Nicein (Formerly BM-600) GB3 im-
munoglobulins from ascites fluid were conjugated to CNBr-activated se-
pharose 4B (Pharmacia, Uppsala, Sweden), at 5 mg of antibody per ml of 
resin, as described by the manufacturer. Columns up to 44 ml resin were 
prepared. 
Medial collected from cultured keratinocytes were clarified by centrifuga-
tion (2000 X g, 10 min) and stored frozen at -20"C. Before chromatogra-
phY, the media were equilibrated with four times concentrated column 
buffer (160 ruM Tris-HCI, pH 7.6,160 mM NaCl , and 8 mM ethylenedia-
mine tetraacetic acid [EOTA]),fi ltered on O.4S-Jim membranes, and loaded 
ontO affinity columns at a flow rate of 200 Jil/min at room temperature. 
After 0.5 - 1 I ofkeratinocyte media had been chromatographed, the column 
was washed with column buffer under absorbance monitoring at 280 nm, 
and the antigen was eluted with 50 mM diethylamine. Pooled fractions were 
immediately brought to neutral pH with 1 M acetic acid and dialyzed over-
night against distilled water before lyophilization. Conditioned media ,:ere 
submitted to two chromatography cycles. The prote1l1 concent of punfied 
fractions was determined and examined by sodium dodecylsulfate polyacryl-
amide gel electrophoresis (SOS-PAGE) for nicein amount and quality. 
TissueS Eleven H-]EB skin biopsies were used: five fetuses at 20-21 
weeks of gestation (88-618, 86-418, 89-706, 89-732, 89-771), five 
infants (87 - 471, GB-BR, BG-]O, GB-AL, BG-BI), and one child (GB-MI) . 
lnal l cases, H-JEB was diagnosed according to the revised clinical criteria for 
lUbryping inherited epidermolysis bullosa [4] . The level of cleavage in all 
lesional skin samples from each patient or fetus was confirmed according to 
immunofluorescence mapping of bullous pemphigoid antigen,laminin, and 
type IV collagen, and by transmis~ion electron microscopy demonstrating.a 
dtrmo-epiderrnal split at the lamllla luclda. In several cases, when techl11-
cally possible, a hemidesmosome abnormality was also demonstrated. All 
HoJEB skin biopsies were non reactive with GB3 by immunofluorescence, 
= pt one case where the labeling was very weak (see Table I) . Skin was also 
biopsied from nine nH-]EB (eight adults and one baby) and three OEB (two 
recessives and one dominant) patients diagnosed according to the Consensus 
report of the National Epidermolysis Bullosa Registry (U .S.A.). Normal 
faa! skin was obtained from 18 - 24-week fetuses and served as controls. 
Adult normal skin biopsies were from healthy volunteers. 
Pleparation oE"Polyclonal Antibodies Against the Niccin Subunits 
Immunization oj Rabbits: Nicein obtained from immuno-chromatography 
..-a5 subjected to SOS-PAGE according to Laemmli [24] under reduced con- . 
dirions. This procedure allows a full separation and a rotal purification of 
IrUctin subunits as checked by protein microsequencing data (not shown) . 
Such immunizations were performed according to the procedure ofDiano et 
1 ~1 [25], using the SDS-PAGE- transblotted protein subunits of nicein onto a 
Aiuoceilulose membrane (0.45 J1m BA 85; Schleicher & Schuell, Dassel, 
I West Germany) . Nitrocellulose strips correspo.nding ro the three niccin 
lIlbunits were cut 111 small pieces and s0111cated III a stenle phosphate-buf-
fered saline solution (PBS) and injected subcutaneously into three rabbits, 
following this schedule: 100 - 150 Jig of protein were injected at day 0; 
50-75 J1g at day 26, and 50-75 ttg at day 68. The antisera obtained were 
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termed Pal00, Pa12S, and Pal SO, reacting, respectively, with the 100-, 
125-, and 150-kO purified nicein subunits. 
Affillity Purificatioll oJtlre Alltibodies: A method adapted from Olmstead [26] 
and D'Angelo Siliciano et af [27] was used. Briefly, each subunit of nicein was 
electro-transferred onto a nitrocellulose sheet. Strips bearing each subunit 
were saturated with PBS containin g 3% bovine sentm albumin (A 7030; 
Sigma, St. Louis, MO), 0.2% Triton X IOO, and 0.02% NaN3 (saturation 
buffer) and then i111mersed into the corresponding sera to be purified under 
gentle .shaklllg for 2 - 3 h at r00111 temperature. Strips were thcn rinsed in 
saturatIOn buffer for 30 mill, and transferred into a siliconized tube to which 
0.05 M acetic .acid was added for immunoglobulin desorption. Purified 
1111111unoglobu llllS were IInmediately buffered ro pH 7 with 2N NaOH and 
stored at 4" C. After seve:al identical cycles on the same aliquot of sentm, the 
pooled neutraltzed fractions were dialyzed against 5 I of PBS made 1 : 10, 
concentrated under vacuum (Speed Vac; Savant, Farmingdale, NY) and 
stored at - 20· C. 
ImmuDoblotting Electrophoresed proteins were transferred overnight 
onto a 111trocel lulose sheet (0.45 J1m, BA 85; Schleicher & Schuell) at 37 V, 
4"C, in a Transblor Cell Biorad apparatus (Richmond, CAl according to 
To~bin et af [28]. The standard procedure of Burnette et al [29] was used for 
the Immunochemistry. The purified antibodies against niccin subunits were 
a.llowed to bind for 2 - 3 h at r00111 tcmperature. An avidin-biotin amplifica-
tIOn system was used (Vectastain PK 4000 kit; Vector Laboratories, Burlin-
game, CAl, devised by the manufacturer, using a biotinylated anti-total IgG 
second antibody (BA 1000, Vector) . 
Immunohistology, Immunoelectron-Microscopy Sections of tissues 
or cultured cells (4 tlln thick) were mounted 011 microscope slides, air-dried 
at room temperature, and processed as already described for indirect immu-
nofluorescence [17,18]. The antibody aga inst the 1S0-kD subunit was used 
at dilution 1 ; 50, and antibodies against the 100- and 125-kO subunits at 
dilution 1: 10: Avidin-biotin amplilication was performed on all slides with 
no sta l~lllg With Pa100 and Pa125 to ensure it was really absent. 
For Immunoelectron-microscopy, small pieces « 1 mm3) of normal skin 
were washed in PBS, incubated with primary antibody (GB3 or polyclonals) 
ovef1~lght, washed 111 PBS, incubated with 1 mm immunogold (Amersham, 
Bucklllphamsl!lre,. UK), washed again in PBS, fixed in half-strength Kar-
no~sky s solution 111 cacodylate buffer for 4 h at room temperature, washed 
agam In PBS, transferred to 0.25 M citrate buffer, pH 7.4, subjected to a 
"Silver enhancement" reaction (Amersham) to increase the size of the 1-111J11 
gold particles, and finally processed through secondary fixation with 05-
mJUlll tetr~xlde (OsO.), and dehydration and embedding for transmission 
electron microscopy as outlined previously [30]. Semithin scctions for light 
m1croscopy With R1chardson's stain, and ultrathin sections were counter-
stained with uranyl acetate and examined in aJEOL 100CX ~Iectron micro-
scope. 
RESULTS 
Specificity of Anti-Nicein Polyclonal Antibodies PalOO, 
Pa12S, and PalSO The isolation of sufficient amounts of nicein 
by affinity. chromatography a llowed the preparation of the poly-
clonal antIbodIes Pa100, Pa12S, and PalSO, directed against the 
.100- , 12S- and lS0-kD nicein subunits purified by SDS-PAGE. On 
Immunoblots, th ese antibodies recognized epitopes beared by the 
2-mercaptoethanol- reduced subunits of nicein isolated by affinity 
chromatography (Fig 1A). 
Inte restin g ly, at hi g her concentrations of reduced nicein, some 
degree of cross-reactivity was detected between Pal 00 and the 1S0-
kD subunit (resolved here as a 146-1S0-kD doublet (18)) and be-
tween Pa1S0 and the 100-kD subunit (Fig IB). In such conditions, 
the PalSO antibody also reacts weakly with a 130-kD polypeptide 
t~at was preVIOusly found to be present in some preparations of 
111cem [18]. ThIS recIprocal cross-reactivity provides evidence for 
common epitopes shared both by the 100- and the 130-kD poly-
peptide and the 146 - ISO-kD doublet. A mixture of these antibod-
ies also reacted with the unreduced form of the nicein as each 
antibody did (data not shown). ' 
We also checked for a cross-reactivity of the polyclonal antibod-
ies with epidermal BM components ultrastructura lly localized close 
to or in the same area as nicein. Anti-Iaminin, anti-nidogen , and 
anti-collagen IV sera were reacted with antigens run on SDS-PAGE 
and transferred to a nitrocellulose sheet. Tn Fig 2 , the lack of cross-
reactivity of the polyclonal antibodies against nicein subunits with 
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Figure L Specific binding of the polyclonal antibodies Pal 00, Pa12S, and 
Pal SO on blotted affinity-isolated nicein. Purified antibodies were diluted 
1 : 500 and used with an avidin-biotin amplification system. A) Reactivity of 
the polyclonal antibody named on top of each lalle with 0.4 jig of 2-
mercaptoethanol - reduccd nicein. Control , Non-immune rabbit serum di-
luted 1 : 500; B) Cross-reactivity of polyclonal antibodies PalOO and PalSO 
with 1 tlg of 2-mercaptoethanol-reduced nicein. Mr, molecular weight in 
kO (A and B; 6% acrylamide gels; C, 3% acrylamide gel). 
any of these proteins is clearly demonstrated, whereas these antigens 
reacted with their respective antibodies, giving characteristic bands. 
Indirect ImmunofluOl:escence and Ilnmunoclcctron-lni-
croscopy Studies with Polyclonal Antibodies Pal00, Pa12S, 
. and PalS0 on Normal Human Skin The polyclonal antibod-
ies used in immunofluorescence studies on normal skin reacted with 
the epidermal BM (Fig 3A) and the tissue distribution of fluores-
cence was similar to that reported for the antibody GB3 (data not 
shown) [17 ,20]. A strong linear labeling of the epidermal BM was 
clearly seen. BM of blood vessels 'and nerves were not stained (data 
not shown). The Pal 00 antibody (and, variably, the Pal25 and the 
aC 
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LN 
p 
C LN 
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c LN 
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--220 
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Figure 2. Immunoblot cross-reactivity of Pal 00, Pa12S, and Pal SO poly-
clonal antibodies with collagen rV,laminin,.and nidogen. 0.8 fig of collagen 
IV (C) and 0.4 tlg of the laminin-nidogen complex (LN) were run on 
50S-PAGE and transferred onto a nitrocellulose sheet as indicated in Materi-
als alld Methods. These nitrocellulose sheets were reacted as indicated with: 
aC, anti-collagen IV antibody (I : 800 dilution); aLN, anti-Iaminin plus 
anti -nidogen antibodies (1 : 1000 dilution each); P, mixture of polyclonal 
antibodies PalOO, Pa12S, and Pal SO (1 : 300 dilution each); control, non-
immune rabbit serum (1 : 300 dilution). Mr, molecular weight in kD (6%, 
2-mercaptoethanol-reduced acrylamide gel). 
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Figure 3. Immunofluorescence analysis with the polyclonal antibodi6 
PalOO, Pa12S, and PalSO on normal human (A,B,C) and H-JEB (D,E Fl 
skin. A, PalOO (dil .l : 1.0); B, Pal2S (diL 1 : 10); C, Pal SO (niL 1 : 50): [p 
normal skill , all antlbodles bllld to the epidermal BM. In addition, PalO) 
also stains the basal cells, accounting for cytoplasmic detection of nice in (AJ 
In H-JEB skll1, Pal SO gIV es the typical fluorescence pattern as in norm~ 
skin (F) , whereas the stainin g is reduced with Pa lOO (D) and absent witb 
Pa125 (E) (> and < indicate the position of epidermal BM). Bar, 25 tlm. 
Pa1S0) also showed a specific intracellular fluorescence of b~ 
keratinocytes, probably indicating the detection of cytoplasmic rtf 
celll. 
To accurately define the location of nicein within the epidenJ 
BM, we performed an ultrastructural analysis by immuno-gala 
electron-microscopy using GB3 and the polyclonal antibodies (Fi£ 
4) . With GB3, gold labeling occurred in the deeper part of chi 
lamina lucida, mainly underneath hemidesmosomes close to chi 
border of lamina densa. As expected, immunolabeling with each J 
the polyclonal antibodies against nice in subunits showed the saDl( 
localization as for GB3. In some places , whatever the antibody usee. 
the gold particles were associated with parts of anchoring filameo¢ 
that span lamina lucida between the hemideslTIosome and the laD!' 
ina densa (see, for instance, in Fig 4 "GB3"). 
Indirect Immunofluorescence Studies with Polyclonal Anti' 
bodies Pal00, Pa12S, and Pa150 on Skin from H-JEB aJ)J 
Other Epidermolysis Bullosa Patients In immunofluoref 
cence studies using the polyclonal antibodies 011 H-JEB skin, "i 
observed variable expression of Ilicein subunits. Fig 3D-F showsl 
representative experiment from 11 H-JEB patients analyzed al!; 
recorded in Table 1. In all cases, Pa150 showed linear f1uorescenti 
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Figure 4. Electron micrographs showing immunog?ld labeling of the epi-
dermal basement membrane by GB3 monoclon~1 antlbo~y (a) and the p.oly-
clonal antibody recognizing the 150-kD subumt of n1cem: b) Go!d partIcles 
l.te localized principally to the interface between the lamma luelda (II) and 
I.nuna densa (Id) underneath hemidesmosomes (hd, arrol~!teads) . Bar, 0.25 tim. 
of ariable intensity, in some cases equivalent to normal skin, in 
Oth:rs slightly reduced. Pa100 staining was slight or not detectable 
and no fluorescence at all could be detected with Pa125, except in 
one case where it was very weak. Titration experiments were per-
formed by indirect immunofluorescence to confirm that the absence 
Otteduced intensity of fluorescence was not due to a P?or titer of the 
antibodies, limiting detection of low amounts of antigen. For each 
batch of Pa100 and Pa125 antibody, the weak.ness or.lac~ of fluo-
rescence observed in H-JEB skin occurred at lugher dtiutlOns than 
tbose corresponding to the disappearance ~f fluorescenc~ observed ~'ith normal skin (data not shown). As. u~ our precedlI:~ set of 
eXperiments, we had not achieved the 11I11It of the sensltlvlty of 
detection. Thus, we concluded that faintness of f1u?rescen~e was 
really due to limited or absent binding sites for the given antlb~dy. 
These studies were extended to some nH-JEB and DEB pat~ent 
Ikin samples (data not shown) . In nine nH-JEB sampl~s, GB3 Im-
~Unoreactivity was detectable, althou~h generally less II1tense than 
In normal control skin. In both the mne nH-JEB and three DE~ 
(two recessive and one dominant) skin samples, all polyclonal antl-
~dies to nicein were found to bind to their respective antigen, but 
the fluorescence was genera lly less bright in nH-JEB than in control 
skill.. 
Indirect Immunofluorescence Studies with Pal00, Pa125, 
and Pa150 Polyclonal Antibodies on Normal and H-JE:O 
Cliltured Keratinocytes On cultured normal kerat1I1ocytes (Fig 
S-i-C), the three antibodies gave a similar intracellular pattern. As 
NICEIN IN HERLITZ'S JUNCTIONAL EPIDERMOLYSIS BULLOSA 741 
previously depicted by the GB3 m.onoclonal antibody, the poly-
clonal antibodies showed that only the cells 111 contact WIth the 
culture dish express significant amounts of the protein .. On cultured 
H -JEB keratinocytes (Fig 5D- F), the po lyclonal antIbody PaI50 
was able to detect intracellular nice in, whereas Pa100 prOVIded 
only a faint labeling for some of the cells. No fluorescence higher 
than the background could be seen with Pa125. 
DISCUSSION 
We have isolated sufficient amounts of nicein from conditioned 
medium of cultured human keratinocytes and produced polyclonal 
antibodies to study additional features of the protein. Raising such 
polydonal antibodies (Pal 00, Pa125, and Pa1S0) directed towards 
each of the denatured protein subunits provides us with probes 
recognizing nice in subunits regardless of their secondary conforma-
tion. This is not the case for the monoclonal antibody GB3, which is 
unable to recognize the 2-mercaptoethanol- reduced form of ni-
cein. The specificity of antibodies is ascertained by several data. 
Firstly, they were obtained from immunizations performed from 
SDS-PAGE purification of nicein subunits after affinity chroma-
tography isolation of the whole protein. This avoids contamination 
of immunogens with possible co-purified proteins from the chro-
matography step. Secondly, immuno-gold electron-microscopy 
shows that the three subunits, as recognized by the polyclonal anti-
bodies, are localized to the same very similar hemidesmosome-re-
Iated sites as is nicein. Thirdly, no immunologic cross-reactivity was 
detected by immunoblotring with laminin, nidogen, and collagen 
IV, which are all major BM proteins. Because there is a lack of 
binding of both 19-DEJ-1 and GB3 in the skin of H-JEB patients 
[31,32], the question is raised whether the antigens recognized by 
these antibodies are the same. Even though these antigens are both 
related to hemidesmosomes, the evidence against them being iden-
tical is suggested by the following. First GB3 antigen is confined to 
epithelial BM whereas 19-DEJ-1 antigen is also found in the BM of 
smooth muscle [33] . Second, in 1 M NaClsplit skin, GB3 stains the 
base of the split whereas 19-DEJ-l only stains the roof [33]. Third, 
our immunoelectron microscopic study shows that GB3 and the 
three polydonal antibodies that recognize nicein subunits all bind to 
very similar, if not identical, sites in the lower part of the lamina 
lucida, at its boundary with the lamina densa. 19-DEJ-1, however, 
recognizes mid-lamina densa epitope, as originally described [33] 
and confirmed by two of us (Ishida Yamamoto and Eady, unpub-
lished) using a similar immunoelectron microscopic procedure to 
that adopted in this study. ImmwlOblotting has shown an absence of 
19-DEJ-1 binding to purified nicein or to nicein subunits (data not 
shown), although identification by immunoblotting of the antigen 
recognized by this antibody has not been reported. 
As already reported [17,18], the molecular weights of the subunit 
antigens recognized by our polydonal antibodies are 100 kD, 125 
kD, and 150 kD. Sometimes, the latter appears to be resolved as a 
146 - 150-kD doublet. Confirming our previous studies, SDS-
PAGE of the chromatography-isolated nicein shows these polypep-
tides are linked by disulfide bonds and assembled into a large protein 
of apparent molecular weight 600 kD (using globular proteins as 
standard molecular weight markers). In some concentrated purified 
preparations, 2-mercaptoethanol reduction of nicein provides an 
additional polypeptide of 130 kD, already mentioned in a previous 
work [18]. Although considerations on both the 146 -150-kD dou-
blet and the 130-kD polypeptides constitutive of nicein are beyond 
the scope of the present report, preliminary unpublished data II1dl-
cate they belong to nicein isoforms secreted into the conditioned 
keratinocyte medium. The presence of SlIch 130- and 146-kD sub-
unit variants does not change the validity of the results presented in 
this report, because our polyclonal antibody Pa1S0 binds to all of 
them and, consequently, to the putative different iso-niceins. The 
iml11unoblots in Fig 1 even provide the information that common 
epitopes may be shared by the 146-1S0-kD do~blet, the 130-kD 
subunit when detected, and the 100-kD subumt. An alternative 
explanation would be that the corresponding immunogens were 
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Figure 5. Indirect immunoflorescence using the PalOO. Pa12S. and PaIS0 polyclonal antibodies on normal and H-JEB -cultured human keratinocytes.A 
cross-section of the cell layers is shown. The polyclonal antibodies were used at same dilutions as in Fig 3. A,B,C, normal keratinocytes; D,E,F, H-JEll 
keratinocytes. A and D, PalOO reactivity; Band E, PaI2S reactivity; C and F, PalSO reactivity. Bar, 10 11m. 
cross-contaminated or that the individual components are closely 
related (i .e., degradation etc.). 
The occurrence of blistering at the dermo-epidermal junction in 
H-JEB i'1 vitlo, as well as the impaired cell-substratum adhesion of 
H-JEB cultured keratinocytes [21] suggest that nicein plays a role 
both in cell adhesion and in BM cohesiveness. Specific lack of im-
munofluorescence or the strongly altered immunoreactivity were 
previously reported using GB3 on tissues and cell cultures from 
H-JEB patients [14 - 17,20,22] suggests either an absence of nicein 
synthesis or changes in its primary structure with epitope disappear-
ance. 
The present indirect immunofluorescence analysis, performed 
both i" tlivo and i" vitro, shows these polyclona l antibodies provide 
new clues in H-JEB by supporting the latter hypothesis . In addition, 
our study demonstrates that the immunoreactivity of the polyclonal 
antibodies against nicein is still observed in nH-JEB and DEB skiD 
samples, although generally less intensely in nH-JEB than in coo' 
trol skin. Thus, Pa100, Pa12S, and Pa1S0 antibodies are mostly 
useful for studying H-JEB, rather than nH-JEB or DEB. 
Whereas the reactivity of GB3 is either absent or only faint ill 
H-JEB cells or tissues, Pa1S0 reactivity, by contrast, is either nor' 
mal or only sli ghtly reduced as assessed by immunofluorescence-
PatOO and Pa12S showed a low reactivity or a lack of labeling ill 
the disease. A proposed explanation of these results is that nicein i; 
synthesized and assembled in an altered tertiary form. The;( 
changes in protein structure lead to a decrease (100- and IS0-kV 
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subunits) and/ or a disappearance (100- and/or 12S-kD subunits) of 
the numbe r of antigen-reactive sites. Also, it should be noticed that 
part of the reactivity observed in some cases with PalOO may be 
attrib u t e d to a cross-reactIvIty wIth the lS0-kD subulllt, as demon-
strated by the immunoblot experiments. Such changes in the pro-
tein produced by H-JEB keratinocytes could explain the disappear-
anCe or the modification of the GB3 epitope and, consequently, the 
absence or reduced imm unoreactivity of the nicein antigen with 
GB3. The remaining reactivity of the GB3 epitope in some H-JEB 
samples could be explained in the light of what happens for some 
other gen e tic diseases such as osteogenesis imperfecta, where mild 
CO severe sub-types can be distin guished according to different mu-
cations in type I procollagen genes [34]. It could be hypothesized 
that diffe r e nt mutations along H-JEB DNA sequences may affect 
different sites on the nice in protein sequence, thus modifying more 
or less the configuration and immuno-reactivi ty of the GB3 epitope 
(the sam e applies to the polyclonal antibodies epitopes) . The loca-
cion of such mutations may define phenotypic H-JEB sub-types and 
some nH-JEB and might explain the variable clinical features of 
JEB (1 - 4] . Undoubtedly, this remains to be ascertained by studying 
the structure of DNA sequences encoding for nicein subunits. 
How eve r, the modifications of nicein structure in H-JEB suggested 
by the present data probably lead to the loss of its fun ctional domains 
and could participate in defective BM cohesion and cell attachment. 
It would be interesting to characterize such functional domains in 
future bioc hemical studies. 
A furthe r usefu l approach would be to perform immunoblots or 
irnmunoprecipitations with Pa100, Pa 12S, and PcdSO on cultured 
keratinocytes from H-JEB patients and to analyze the protein bio-
chemically. During the course of this study we have been unable to 
culrure enough cells suitable for such experiments, mainly because 
H-JEB is a ra re disease and biopsies are difficult to obtain. Never-
theless, the present work opens perspectives for the understanding 
of H-JEB a t the molecular level. The polyclonal antibodies against 
the purifie d subunits of nicein represent very usefu l tools that have 
allowed u s to undertake screening of an epidermal cDNA library in 
order to e stablish the protein sequence of tbe molecule and to ana-
lyze the mutation(s) in H-JEB. 
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